1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Stomach 1.2.3 Small Intestine 1.2.4 Others 1.3 Market by Application 1.3.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Specialized Cancer Treatment Centers 1.3.5 Other End Users 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2016-2027) 2.2 Gastrointestinal Stromal Tumor Growth Trends by Regions 2.2.1 Gastrointestinal Stromal Tumor Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gastrointestinal Stromal Tumor Historic Market Share by Regions (2016-2021) 2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2022-2027) 2.3 Gastrointestinal Stromal Tumor Industry Dynamic 2.3.1 Gastrointestinal Stromal Tumor Market Trends 2.3.2 Gastrointestinal Stromal Tumor Market Drivers 2.3.3 Gastrointestinal Stromal Tumor Market Challenges 2.3.4 Gastrointestinal Stromal Tumor Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue 3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2016-2021) 3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2016-2021) 3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue 3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio 3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2020 3.5 Gastrointestinal Stromal Tumor Key Players Head office and Area Served 3.6 Key Players Gastrointestinal Stromal Tumor Product Solution and Service 3.7 Date of Enter into Gastrointestinal Stromal Tumor Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gastrointestinal Stromal Tumor Breakdown Data by Type 4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2016-2021) 4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2022-2027) 5 Gastrointestinal Stromal Tumor Breakdown Data by Application 5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2016-2021) 5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gastrointestinal Stromal Tumor Market Size (2016-2027) 6.2 North America Gastrointestinal Stromal Tumor Market Size by Type 6.2.1 North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) 6.2.2 North America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) 6.2.3 North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2027) 6.3 North America Gastrointestinal Stromal Tumor Market Size by Application 6.3.1 North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) 6.3.2 North America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) 6.3.3 North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2027) 6.4 North America Gastrointestinal Stromal Tumor Market Size by Country 6.4.1 North America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) 6.4.2 North America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Gastrointestinal Stromal Tumor Market Size (2016-2027) 7.2 Europe Gastrointestinal Stromal Tumor Market Size by Type 7.2.1 Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) 7.2.2 Europe Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) 7.2.3 Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2027) 7.3 Europe Gastrointestinal Stromal Tumor Market Size by Application 7.3.1 Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) 7.3.2 Europe Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) 7.3.3 Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2027) 7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country 7.4.1 Europe Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) 7.4.2 Europe Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2016-2027) 8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type 8.2.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2027) 8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application 8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2027) 8.4 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region 8.4.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2016-2027) 9.2 Latin America Gastrointestinal Stromal Tumor Market Size by Type 9.2.1 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) 9.2.2 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) 9.2.3 Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2027) 9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Application 9.3.1 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) 9.3.2 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) 9.3.3 Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2027) 9.4 Latin America Gastrointestinal Stromal Tumor Market Size by Country 9.4.1 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) 9.4.2 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2016-2027) 10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type 10.2.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2027) 10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application 10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2027) 10.4 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country 10.4.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction 11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 ​​Sun Pharmaceutical 11.2.1 ​​Sun Pharmaceutical Company Details 11.2.2 ​​Sun Pharmaceutical Business Overview 11.2.3 ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction 11.2.4 ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) 11.2.5 ​​Sun Pharmaceutical Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction 11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Bayer Aktiengesellschaft 11.4.1 Bayer Aktiengesellschaft Company Details 11.4.2 Bayer Aktiengesellschaft Business Overview 11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction 11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) 11.4.5 Bayer Aktiengesellschaft Recent Development 11.5 NATCO Pharma 11.5.1 NATCO Pharma Company Details 11.5.2 NATCO Pharma Business Overview 11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction 11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) 11.5.5 NATCO Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Stomach Table 3. Key Players of Small Intestine Table 4. Key Players of Others Table 5. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Gastrointestinal Stromal Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Gastrointestinal Stromal Tumor Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Gastrointestinal Stromal Tumor Market Share by Regions (2016-2021) Table 9. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Gastrointestinal Stromal Tumor Market Share by Regions (2022-2027) Table 11. Gastrointestinal Stromal Tumor Market Trends Table 12. Gastrointestinal Stromal Tumor Market Drivers Table 13. Gastrointestinal Stromal Tumor Market Challenges Table 14. Gastrointestinal Stromal Tumor Market Restraints Table 15. Global Gastrointestinal Stromal Tumor Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Gastrointestinal Stromal Tumor Market Share by Players (2016-2021) Table 17. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2020) Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Gastrointestinal Stromal Tumor Product Solution and Service Table 22. Date of Enter into Gastrointestinal Stromal Tumor Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 25. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2016-2021) Table 26. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Gastrointestinal Stromal Tumor Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2016-2021) Table 30. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Gastrointestinal Stromal Tumor Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 33. North America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million) Table 35. North America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2022-2027) & (US$ Million) Table 62. Novartis Company Details Table 63. Novartis Business Overview Table 64. Novartis Gastrointestinal Stromal Tumor Product Table 65. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million) Table 66. Novartis Recent Development Table 67. ​​Sun Pharmaceutical Company Details Table 68. ​​Sun Pharmaceutical Business Overview Table 69. ​​Sun Pharmaceutical Gastrointestinal Stromal Tumor Product Table 70. ​​Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million) Table 71. ​​Sun Pharmaceutical Recent Development Table 72. Pfizer Company Details Table 73. Pfizer Business Overview Table 74. Pfizer Gastrointestinal Stromal Tumor Product Table 75. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million) Table 76. Pfizer Recent Development Table 77. Bayer Aktiengesellschaft Company Details Table 78. Bayer Aktiengesellschaft Business Overview Table 79. Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product Table 80. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million) Table 81. Bayer Aktiengesellschaft Recent Development Table 82. NATCO Pharma Company Details Table 83. NATCO Pharma Business Overview Table 84. NATCO Pharma Gastrointestinal Stromal Tumor Product Table 85. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2016-2021) & (US$ Million) Table 86. NATCO Pharma Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastrointestinal Stromal Tumor Market Share by Type: 2020 VS 2027 Figure 2. Stomach Features Figure 3. Small Intestine Features Figure 4. Others Features Figure 5. Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Specialized Cancer Treatment Centers Case Studies Figure 9. Other End Users Case Studies Figure 10. Gastrointestinal Stromal Tumor Report Years Considered Figure 11. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Gastrointestinal Stromal Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Gastrointestinal Stromal Tumor Market Share by Regions: 2020 VS 2027 Figure 14. Global Gastrointestinal Stromal Tumor Market Share by Regions (2022-2027) Figure 15. Global Gastrointestinal Stromal Tumor Market Share by Players in 2020 Figure 16. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2020 Figure 18. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2016-2021) Figure 19. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2022-2027) Figure 20. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Gastrointestinal Stromal Tumor Market Share by Type (2016-2027) Figure 22. North America Gastrointestinal Stromal Tumor Market Share by Application (2016-2027) Figure 23. North America Gastrointestinal Stromal Tumor Market Share by Country (2016-2027) Figure 24. United States Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Gastrointestinal Stromal Tumor Market Share by Type (2016-2027) Figure 28. Europe Gastrointestinal Stromal Tumor Market Share by Application (2016-2027) Figure 29. Europe Gastrointestinal Stromal Tumor Market Share by Country (2016-2027) Figure 30. Germany Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Type (2016-2027) Figure 38. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Application (2016-2027) Figure 39. Asia-Pacific Gastrointestinal Stromal Tumor Market Share by Region (2016-2027) Figure 40. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Gastrointestinal Stromal Tumor Market Share by Type (2016-2027) Figure 48. Latin America Gastrointestinal Stromal Tumor Market Share by Application (2016-2027) Figure 49. Latin America Gastrointestinal Stromal Tumor Market Share by Country (2016-2027) Figure 50. Mexico Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Type (2016-2027) Figure 54. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Application (2016-2027) Figure 55. Middle East & Africa Gastrointestinal Stromal Tumor Market Share by Country (2016-2027) Figure 56. Turkey Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Gastrointestinal Stromal Tumor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021) Figure 60. ​​Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021) Figure 62. Bayer Aktiengesellschaft Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021) Figure 63. NATCO Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumor Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Novartis ​​Sun Pharmaceutical Pfizer Bayer Aktiengesellschaft NATCO Pharma